Top Pharma News Updates- Glenmark, Lupin, Intas Pharma, Amneal Pharma & Biological E. Limited (BE)
3 ) Lupin gets USFDA approval for Sildenafil Oral Suspension, 10mg/mL
5 ) Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar in the Middle East.
6 ) BE TO GET mRNA TECH FROM WHO TO PRODUCE COVID-19 VACCINES.